Immune checkpoint inhibitor therapy for malignant tumors in liver transplantation recipients: A systematic review of the literature
Author:
Funder
Guangdong Provincial People's Hospital
Publisher
Elsevier BV
Subject
Transplantation
Reference40 articles.
1. Hepatocellular carcinoma recurrence after liver transplantation: risk factors, screening and clinical presentation[J];Filgueira;World J Hepatol,2019
2. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time[J];Yoo;J Clin Oncol,2003
3. Melanoma risk and survival among organ transplant recipients[J];Robbins;J Invest Dermatol,2015
4. Skin cancers after organ transplantation[J];Euvrard;N Engl J Med,2003
5. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: a proposed management algorithm[J];Au;World J Gastroenterol,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Liver Resection and Transplantation in the Era of Checkpoint Inhibitors;JHEP Reports;2024-08
2. Pharmacological management of invasive mold infections in solid organ transplant recipients;Expert Opinion on Pharmacotherapy;2024-02-11
3. Immunotherapy in the Solid Organ Transplant Recipient;The Basics of Cancer Immunotherapy;2024
4. Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis;Annals of Liver Transplantation;2023-11-30
5. Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data;Cancers;2023-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3